Aleksandar Danilovski

Director/Board Member at ACTIVE BIOTECH AB

52 year

Health Technology

Consumer Services

Retail Trade

Profile

Aleksandar Danilovski is the founder of Dalisco doo, established in 2023, serving as Managing Partner.
Current jobs include Independent Director at Active Biotech AB since 2020, Director at Pharmaero ApS, and Chief Scientific Officer at Xellia Pharmaceuticals ApS since 2020.
Former jobs include Principal at PLIVA, Inc., Head-European Research & Development at Barr Laboratories, Inc., Member-Management Board at PLIVA Pharmaceuticals, Inc., Principal at The Barr Group, Inc., Member-Management Board at PLIVA Croatia Ltd. from 2011 to 2012, and Member-Scientific Selection Board at Novo Holdings A. Education includes a doctorate from the University of Cambridge and both undergraduate and doctorate degrees from the University of Zagreb.

Aleksandar Danilovski active positions

Companies	Position	Start
ACTIVE BIOTECH AB	Director/Board Member	2019-12-31
Xellia Pharmaceuticals ApS Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services	Chief Tech/Sci/R&D Officer	2019-12-31
Pharmaero ApS	Director/Board Member	-

All active positions of Aleksandar Danilovski

Former positions of Aleksandar Danilovski

Companies	Position	End
PLIVA Pharmaceuticals, Inc.	Corporate Officer/Principal	-
Barr Laboratories, Inc. Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals	Corporate Officer/Principal	-
Novo Holdings A/S (Investment Company) Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives.	Corporate Officer/Principal	-
PLIVA Croatia Ltd.	Director/Board Member	-
The Barr Group, Inc. The Barr Group, Inc. The Barr Group, Inc. is a private company based in Nashville, TN.	Corporate Officer/Principal	-

See the detail of Aleksandar Danilovski's experience

Training of Aleksandar Danilovski

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Aleksandar Danilovski's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Active Biotech AB Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PLIVA, Inc. PLIVA, Inc. Drugstore ChainsRetail Trade Develops, produces, and sells drugs and pharmaceutical products	Retail Trade
University of Zagreb University of Zagreb Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Barr Laboratories, Inc. Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals	Health Technology
PLIVA Pharmaceuticals, Inc.
Xellia Pharmaceuticals ApS Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services	Health Services
The Barr Group, Inc. The Barr Group, Inc. The Barr Group, Inc. is a private company based in Nashville, TN.
PLIVA Croatia Ltd.
Novo Holdings A/S (Investment Company) Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives.	Finance
Pharmaero ApS